drugset / Trial / NCT01980992

Oral Immunotherapy for Wheat Allergy

NCT01980992 ↗

Phase 1/2 Completed 46 enrolled Hugh A Sampson, MD
RandomizedCrossoverTriple-blindTreatment

Summary

This study is being done to learn about the medical effects, the safety, and the immunologic effects of Wheat Oral Immunotherapy (OIT) treatment. The goal of the study is to find out whether subjects can develop the ability to eat wheat (the food allergen) regularly without allergic symptoms after stopping the study treatment.

Timeline

Start
2013-10
Primary completion
2015-11
Completion
2017-04-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vital Wheat Gluten Unknown — Oral

Indications